Aktuellt
SENASTE
Redeye finds the strategy to launch ASTar gradually. We can expect the first step to start very soon and this will include the most suitable centres. Future volume sales and orders are likely to follow on the back of real-life evidence and clinical support from this initial controlled launch stage. Q-linea's European approval yesterday has opened the door to Q-linea's commercial and clinical stage.
LÄS MER
